Efficacy of Oral DFD-29, a Low-Dose Minocycline Formulation, in Patients in Germany and Patients in the US: An Analysis of Two Phase 3 Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s765, 2026. DOI: 10.25251/kf0b7204. Disponível em: https://skin.dermsquared.com/skin/article/view/4036. Acesso em: 2 may. 2026.